References
- Dumonteil E. Update on Chagas disease in Me´xico. Salud Pu´ blica Mex 1999;41:322–327.
- World Health Organization. Chagas disease Special Program for Research and Training in Tropical Diseases. 1993. p 67–75.
- World Health Organization Control of Chagas disease. Tech Rep Ser 2002;905:1–109.
- Moncayo A. Progress towards interruption of transmission of Chagas disease. Mem Inst Oswaldo Cruz 1999;94:401–404.
- Petray PB, Morilla MJ, Corral RS, Romero EL. In vitro activity of etanidazole against the protozoan parasite Trypanosoma cruzi. Mem Inst Oswaldo Cruz 2004;99:233–235.
- Urbina JA. Parasitological cure of Chagas disease: Is it possible? Is it relevant? Mem Inst Oswaldo Cruz 1999;94:349–355.
- Rodrigues-Coura J, de Castro SL. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 2002; 97:3–24.
- Opperdoes FR. Biochemical peculiarities of trypanosomes African and South American. Br Med Bull 1985;41:130–136.
- Bakker BM, Westerhoff HV, Opperdoes FR, Michels PAM. Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs. Mol Biochem Pharmacol 2000;106:1–10.
- Verlinde CL, Hannaert V, Blonski C, Willson M, Perie JJ, Fothergill-Gilmore LA, Opperdoes FR, Gelb MH, Hol WG, Michels PA. Glycolysis as a target for the design of new anti-trypanosome drugs. Drug Resist Update 2001;41:130–136.
- Gerez de Burgos NM, Burgos C, Blanco A, Paulone I, Segura EL. Actividad de alfa-hidroxia´cido deshidrogenasa en Trypanosoma cruzi. Acta Physiol Latinoam 1976;26:10–19.
- Coronel CE, Rovai LE, Gerez de Burgos NM, Burgos C, Blanco A. Properties of a-hydroxyacid dehydrogenase isozymes from Trypanosoma cruzi. Mol Biochem Parasitol 1981;4:29–38.
- Montamat EE, Arauso SS, Blanco A. Subcellular localization of leucine aminotransferase and a-hydroxyacid dehydrogenase in Trypanosoma cruzi. Mol Biochem Parasitol 1987;22:185–193.
- Gerez de Burgos NM, Burgos C, Montamat EE, Rovai LE, Blanco A. Inhibition by gossypol of oxidoreductases from Trypanosoma cruzi. Biochem Pharmacol 1984;33:955–959.
- Elizondo S, Chena MA, Rodr´ıguez-Pa´ez L, Nogueda B, Baeza I, Wong C. Inhibition of Trypanosoma cruzi a-hydroxyacid dehydrogenase isozyme II by N-isopropyl oxamate and its effect on intact epimastigotes. J Enz Inhib Med Chem 2003;18:265–271.
- Bronfen E, Rocha FSA, Machado GBN. Isolamento de amostras do Trypanosoma cruzi por genodiagnostico e hemoculture de pacientes na fase cronica da doenca de Chagas. Mem Inst Oswaldo Cruz 1989;84:234–240.
- Chiairi E, Diaz JCP, Lana M, Chiari CA. Haemocultures for the parasitological diagnosis of human chronic Chagas disease. Rev Soc Bras Med Trop 1989;22:19–23.
- Brener Z. Recent advances in the chemotherapy of Chagas’ disease. Mem Inst Oswaldo Cruz 1984;79:149–155.
- Urbina JA, Payares G, Contreras LM, Liendo A, Sanoja C, Molina J, Piras M, Piras R, Perez N, Wincker P, Luebenberg D. Antiproliferative effects and mechanism of action of SCH56592 against Trypanosoma cruzi: In vitro and in vivo studies. Antimicrob Agents Chemother 1998;42:1771–1777.
- Filardi LS, Brener Z. A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agents. Mem Inst Oswaldo Cruz 1984;79:221–225.
- Barr JC, Rose D, Jaines JM. Activity of lytic peptides against intracellular Trypanosoma cruzi amastigotes in vitro and parasitaemia in mice. J Parasitol 1995;81:974–978.
- NIH. Guide for the care and use of laboratory animals. Office of Science and Health Report, DRR/NIH DHEW Publication. 1985. p 85–123.
- Aldunate J, Repetto Y, Letelier ME, Morello A. The carboxyl esterases of Trypanosoma cruzi epimastigotes. Comp Biochem Physiol 1987;86:67–71.
- Repetto Y, Aldunate J, Morello A. Trypanosoma cruzi: Carboxylesterase activity in intact epimastigotes. Comp Biochem Physiol B 1983;76:61–64.
- Docampo R. Sensitivity of parasites to free radicals damage by parasitic drugs. Chem Biol Interact 1990;73:1–27.